To study the efficacy of Arthocan J100 Lep Powder in patients with Rheumatoid Arthritis(Aamvata)

A Pilot Exploratory Clinical Study To Evaluate the efficacy of local application of Arthocan-J100 Lep Powder in Rheumatoid Arthritis (Aamvata) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/077317

Enrollment

Registered

2024-11-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having Inflammation of joints (Sandhi shotha) 2.Joint pain (Sandhi shool) 3.Restriction of joint movements (Sandhigraha) 4.Tenderness (Sparsha asahatva)

Exclusion criteria

Exclusion criteria: 1.Known case of Uncontrolled Diabetes Mellitus. 2.Known case of Vatarakta and Sandhigata vata. 3.Known case of Ankylosing Spondylosis

Design outcomes

Primary

Measure	Time frame
Primary Outcome-Reduction in Sandhi shotha (inflammation of joint) by using the measuring tape before and after treatment with Local Application ArthoCan-J100 Lep Powder.Timepoint: 14 days	—

Secondary

Measure	Time frame
Secondary Outcome- Reduction in Sandhi shool (Pain in joints) using the VAS scale before and after treatment with Local Application ArthoCan-J100 Lep Powder.Timepoint: 14 days	—

Countries

India

Contacts

Public ContactDr Pranesh P Gaikwad

Dr. D.Y.Patil College of Ayurved and Research Centre, Pimpri Pune-18

pranesh.gaikwad@dpu.edu.in8668259365

Outcome results